These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
|||||
|
|
|||||
|
For the quarterly period ended
|
|||||
|
OR
|
|||||
|
|
|||||
|
For transition period from to
|
|||||
|
Commission File Number
|
|||||
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification Number)
|
||||||||||
|
(
|
|||||||||||
|
(Address of principal executive offices and zip code)
|
|||||||||||
|
(
|
|||||||||||
|
(Registrant's telephone number, including area code)
|
|||||||||||
|
___________________________________
|
|||||||||||
| Securities registered pursuant to Section 12(b) of the Act: | ||||||||
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
Accelerated filer
o
|
||||
|
Non-accelerated filer
o
|
Smaller reporting company
|
||||
|
Emerging growth company
|
|||||
|
Page
|
|||||||||||
|
Item 1
.
|
|||||||||||
|
WORKIVA INC.
CONSOLIDATED BALANCE SHEETS
|
|||||||||||
| (in thousands, except share and per share amounts) | |||||||||||
| As of September 30, 2025 | As of December 31, 2024 | ||||||||||
|
(unaudited)
|
|||||||||||
| ASSETS | |||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Marketable securities |
|
|
|||||||||
|
Accounts receivable, net of allowance for doubtful accounts of $
|
|
|
|||||||||
| Deferred costs |
|
|
|||||||||
| Other receivables |
|
|
|||||||||
| Prepaid expenses and other |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
| Property and equipment, net |
|
|
|||||||||
| Operating lease right-of-use assets |
|
|
|||||||||
| Deferred costs, non-current |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Intangible assets, net |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
|
WORKIVA INC.
CONSOLIDATED BALANCE SHEETS (continued)
|
|||||||||||
| (in thousands, except share and per share amounts) | |||||||||||
| As of September 30, 2025 | As of December 31, 2024 | ||||||||||
| (unaudited) | |||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||||||
| Current liabilities | |||||||||||
|
Accounts payable
|
$ |
|
$ |
|
|||||||
|
Accrued expenses and other current liabilities
|
|
|
|||||||||
|
Deferred revenue
|
|
|
|||||||||
| Convertible senior notes, current |
|
|
|||||||||
| Finance lease obligations |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
| Convertible senior notes, non-current |
|
|
|||||||||
|
Deferred revenue, non-current
|
|
|
|||||||||
|
Other long-term liabilities
|
|
|
|||||||||
| Operating lease liabilities, non-current |
|
|
|||||||||
| Finance lease obligations, non-current |
|
|
|||||||||
| Total liabilities |
|
|
|||||||||
| Stockholders’ deficit | |||||||||||
|
Class A common stock, $
|
|
|
|||||||||
|
Class B common stock, $
|
|
|
|||||||||
|
Preferred stock, $
|
|
|
|||||||||
|
Additional paid-in-capital
|
|
|
|||||||||
|
Accumulated deficit
|
(
|
(
|
|||||||||
| Accumulated other comprehensive income (loss) |
|
(
|
|||||||||
| Total stockholders’ deficit |
(
|
(
|
|||||||||
| Total liabilities and stockholders’ deficit | $ |
|
$ |
|
|||||||
|
WORKIVA INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)
(unaudited)
|
|||||||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Revenue | |||||||||||||||||||||||
| Subscription and support | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Professional services |
|
|
|
|
|||||||||||||||||||
| Total revenue |
|
|
|
|
|||||||||||||||||||
| Cost of revenue | |||||||||||||||||||||||
| Subscription and support |
|
|
|
|
|||||||||||||||||||
| Professional services |
|
|
|
|
|||||||||||||||||||
| Total cost of revenue |
|
|
|
|
|||||||||||||||||||
| Gross profit |
|
|
|
|
|||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
| Research and development |
|
|
|
|
|||||||||||||||||||
| Sales and marketing |
|
|
|
|
|||||||||||||||||||
| General and administrative |
|
|
|
|
|||||||||||||||||||
| Total operating expenses |
|
|
|
|
|||||||||||||||||||
| Loss from operations |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Interest income |
|
|
|
|
|||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Other income (expense), net |
|
(
|
(
|
(
|
|||||||||||||||||||
| Income (loss) before provision for income taxes |
|
(
|
(
|
(
|
|||||||||||||||||||
| (Benefit) provision for income taxes |
(
|
|
|
|
|||||||||||||||||||
| Net income (loss) | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Net income (loss) per common share | |||||||||||||||||||||||
|
Basic
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
Diluted
|
|
(
|
(
|
(
|
|||||||||||||||||||
|
Weighted-average common shares outstanding
|
|||||||||||||||||||||||
|
Basic
|
|
|
|
|
|||||||||||||||||||
|
Diluted
|
|
|
|
|
|||||||||||||||||||
|
WORKIVA INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands)
(unaudited)
|
|||||||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net income (loss) | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Other comprehensive (loss) income | |||||||||||||||||||||||
| Foreign currency translation adjustment |
(
|
|
|
|
|||||||||||||||||||
| Unrealized gain on available-for-sale securities |
|
|
|
|
|||||||||||||||||||
| Other comprehensive (loss) income |
(
|
|
|
|
|||||||||||||||||||
| Comprehensive income (loss) | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
WORKIVA INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT
|
|||||||||||||||||||||||||||||||||||
|
(in thousands)
(unaudited) |
|||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, 2025 | |||||||||||||||||||||||||||||||||||
| Common Stock (Class A and B) | |||||||||||||||||||||||||||||||||||
| Shares | Amount | Additional Paid-in-Capital |
Accumulated Other Comprehensive (Loss) Income
|
Accumulated Deficit |
Total Stockholders' Deficit
|
||||||||||||||||||||||||||||||
| Balances at December 31, 2024 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||
| Stock-based compensation expense | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of common stock upon exercise of stock options |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of common stock under employee stock purchase plan |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of restricted stock units |
|
— | — | — | — | — | |||||||||||||||||||||||||||||
| Tax withholding related to net share settlements of stock-based compensation awards |
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
|
Repurchases of Class A common stock
|
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
| Net loss | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||
| Balances at March 31, 2025 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||
| Stock-based compensation expense | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of common stock upon exercise of stock options |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of restricted stock units |
|
— | — | — | — | — | |||||||||||||||||||||||||||||
| Tax withholding related to net share settlements of stock-based compensation awards |
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
| Repurchases of Class A common stock |
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
| Net loss | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||
| Balances at June 30, 2025 |
|
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||
| Stock-based compensation expense | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of common stock upon exercise of stock options |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of common stock under employee stock purchase plan |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of restricted stock units |
|
— | — | — | — | — | |||||||||||||||||||||||||||||
| Tax withholding related to net share settlements of stock-based compensation awards | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
| Repurchases of Class A common stock |
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
| Net income | — | — | — |
|
|
||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
| Balances at September 30, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||
| Nine Months Ended September 30, 2024 | |||||||||||||||||||||||||||||||||||
| Common Stock (Class A and B) | |||||||||||||||||||||||||||||||||||
| Shares | Amount | Additional Paid-in-Capital |
Accumulated Other Comprehensive Income (Loss)
|
Accumulated Deficit |
Total Stockholders' Deficit
|
||||||||||||||||||||||||||||||
| Balances at December 31, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||
| Stock-based compensation expense | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of common stock upon exercise of stock options |
|
|
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of common stock under employee stock purchase plan |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of restricted stock units |
|
— | — | — | — | — | |||||||||||||||||||||||||||||
| Tax withholding related to net share settlements of stock-based compensation awards |
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
| Net loss | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
| Balances at March 31, 2024 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||
| Stock-based compensation expense | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of common stock upon exercise of stock options |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
| Issuance of restricted stock units |
|
— | — | — | — | — | |||||||||||||||||||||||||||||
| Tax withholding related to net share settlements of stock-based compensation awards |
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
| Net loss | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
| Balances at June 30, 2024 |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||
| Stock-based compensation expense | — | — |
|
$ | — | $ | — | $ |
|
||||||||||||||||||||||||||
| Issuance of common stock upon exercise of stock options |
|
|
|
$ | — | $ | — | $ |
|
||||||||||||||||||||||||||
| Issuance of common stock under employee stock purchase plan |
|
— |
|
$ | — | $ | — | $ |
|
||||||||||||||||||||||||||
| Issuance of restricted stock units |
|
— | — | $ | — | $ | — | $ | — | ||||||||||||||||||||||||||
| Tax withholding related to net share settlements of stock-based compensation awards |
(
|
— |
(
|
$ | — | $ | — | $ |
(
|
||||||||||||||||||||||||||
| Net loss | — | — | — | $ | — | $ |
(
|
$ |
(
|
||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | $ |
|
$ | — | $ |
|
||||||||||||||||||||||||||
| Balances at September 30, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||
|
WORKIVA INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|||||||||||||||||||||||
|
(in thousands)
(unaudited) |
|||||||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Cash flows from operating activities | |||||||||||||||||||||||
| Net income (loss) | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities | |||||||||||||||||||||||
| Depreciation and amortization |
|
|
|
|
|||||||||||||||||||
| Stock-based compensation expense |
|
|
|
|
|||||||||||||||||||
| Provision for (recovery of) doubtful accounts |
|
|
(
|
(
|
|||||||||||||||||||
| Accretion of premiums and discounts on marketable securities, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Amortization of debt discount and issuance costs |
|
|
|
|
|||||||||||||||||||
| Deferred income tax |
|
(
|
(
|
(
|
|||||||||||||||||||
| Changes in assets and liabilities: | |||||||||||||||||||||||
| Accounts receivable |
(
|
(
|
|
(
|
|||||||||||||||||||
| Deferred costs |
(
|
(
|
|
(
|
|||||||||||||||||||
| Operating lease right-of-use assets |
|
|
|
|
|||||||||||||||||||
| Other receivables |
(
|
(
|
|
|
|||||||||||||||||||
| Prepaid expenses and other |
(
|
|
(
|
|
|||||||||||||||||||
| Other assets |
(
|
|
|
(
|
|||||||||||||||||||
| Accounts payable |
|
|
|
|
|||||||||||||||||||
| Deferred revenue |
|
|
|
|
|||||||||||||||||||
| Operating lease liabilities |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Accrued expenses and other liabilities |
|
(
|
(
|
|
|||||||||||||||||||
| Net cash provided by operating activities |
|
|
|
|
|||||||||||||||||||
| Cash flows from investing activities | |||||||||||||||||||||||
| Purchase of property and equipment |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Purchase of marketable securities |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Maturities of marketable securities |
|
|
|
|
|||||||||||||||||||
| Sale of marketable securities |
|
|
|
|
|||||||||||||||||||
| Acquisitions, net of cash acquired |
|
|
|
(
|
|||||||||||||||||||
| Purchase of intangible assets |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net cash used in investing activities |
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
WORKIVA INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
|
|||||||||||||||||||||||
|
(in thousands)
(unaudited) |
|||||||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Cash flows from financing activities | |||||||||||||||||||||||
| Proceeds from option exercises |
|
|
|
|
|||||||||||||||||||
| Taxes paid related to net share settlements of stock-based compensation awards |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Proceeds from shares issued in connection with employee stock purchase plan |
|
|
|
|
|||||||||||||||||||
| Repurchases of Class A common stock |
(
|
|
(
|
|
|||||||||||||||||||
| Principal payments on finance lease obligations |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net cash (used in) provided by financing activities |
(
|
|
(
|
|
|||||||||||||||||||
| Effect of foreign exchange rates on cash |
(
|
|
|
|
|||||||||||||||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash |
|
(
|
|
(
|
|||||||||||||||||||
| Cash, cash equivalents, and restricted cash at beginning of period |
|
|
|
|
|||||||||||||||||||
| Cash, cash equivalents, and restricted cash at end of period | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Supplemental cash flow disclosure | |||||||||||||||||||||||
| Cash paid for interest | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cash paid for income taxes, net of refunds | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Noncash investing and financing activities | |||||||||||||||||||||||
| Purchases of property and equipment, accrued but not paid | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets | |||||||||||||||||||||||
| Cash and cash equivalents at end of period | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Restricted cash included within prepaid expenses and other at end of period |
|
|
|
|
|||||||||||||||||||
| Total cash, cash equivalents, and restricted cash at end of period shown in the consolidated statements of cash flows | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| As of September 30, 2025 | As of December 31, 2024 | ||||||||||
| Accrued bonuses | $ |
|
$ |
|
|||||||
| Customer deposits |
|
|
|||||||||
| Accrued vacation |
|
|
|||||||||
| Accrued commissions |
|
|
|||||||||
| Accrued payroll |
|
|
|||||||||
| ESPP employee contributions |
|
|
|||||||||
| Operating lease liabilities |
|
|
|||||||||
| Estimated health insurance claims |
|
|
|||||||||
| Accrued interest |
|
|
|||||||||
| Accrued other liabilities |
|
|
|||||||||
|
Total
|
$ |
|
$ |
|
|||||||
|
Amortized Cost
|
Unrealized Gains
|
Unrealized Losses
|
Aggregate Fair Value
|
||||||||||||||||||||
| Money market funds | $ |
|
$ | — | $ | — | $ |
|
|||||||||||||||
| Commercial paper |
|
|
|
|
|||||||||||||||||||
| U.S. treasury debt securities |
|
|
(
|
|
|||||||||||||||||||
| U.S. government agency debt securities |
|
|
(
|
|
|||||||||||||||||||
| Corporate debt securities |
|
|
(
|
|
|||||||||||||||||||
| $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||
| Included in cash and cash equivalents | $ |
|
$ | — | $ | — | $ |
|
|||||||||||||||
| Included in marketable securities | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
|
Amortized Cost
|
Unrealized Gains
|
Unrealized Losses
|
Aggregate Fair Value
|
||||||||||||||||||||
| Money market funds | $ |
|
$ | — | $ | — | $ |
|
|||||||||||||||
| Commercial paper |
|
|
|
|
|||||||||||||||||||
| U.S. treasury debt securities |
|
|
(
|
|
|||||||||||||||||||
| U.S. government agency debt securities |
|
|
(
|
|
|||||||||||||||||||
| Corporate debt securities |
|
|
(
|
|
|||||||||||||||||||
| $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||
| Included in cash and cash equivalents | $ |
|
$ |
|
$ | — | $ |
|
|||||||||||||||
| Included in marketable securities | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| As of September 30, 2025 | |||||
| Due within one year | $ |
|
|||
| Due in one to two years |
|
||||
| Due in three to five years |
|
||||
| $ |
|
||||
| As of September 30, 2025 | |||||||||||||||||||||||
|
Less than 12 months
|
12 months or greater
|
||||||||||||||||||||||
|
Fair Value
|
Unrealized Loss
|
Fair Value
|
Unrealized Loss
|
||||||||||||||||||||
| U.S. treasury debt securities | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
| U.S. government agency debt securities |
|
(
|
|
(
|
|||||||||||||||||||
| Corporate debt securities |
|
(
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
| Fair Value Measurements as of September 30, 2025 | Fair Value Measurements as of December 31, 2024 | |||||||||||||||||||||||||||||||||||||
|
Description
|
Total
|
Level 1
|
Level 2
|
Total
|
Level 1
|
Level 2
|
||||||||||||||||||||||||||||||||
| Money market funds | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
| Commercial paper |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
| U.S. treasury debt securities |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
| U.S. government agency debt securities |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
| Corporate debt securities |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
| $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Included in cash and cash equivalents | $ |
|
$ |
|
||||||||||||||||||||||||||||||||||
| Included in marketable securities | $ |
|
$ |
|
||||||||||||||||||||||||||||||||||
|
Month Issued
|
Maturity Date
|
Free Convertibility Date
|
Redemption Date
|
Original Principal (including overallotment)
|
Initial Conversion Rate per $1,000 Principal
|
Initial Conversion Price
|
||||||||||||||||||||||||||||||||||||||
|
2026 Notes
|
August 2019 | August 15, 2026 | May 15, 2026 | August 21, 2023 | $ |
|
12.4756 | $ |
|
|||||||||||||||||||||||||||||||||||
|
2028 Notes
|
August 2023 | August 15, 2028 | May 15, 2028 | August 21, 2026 | $ |
|
7.4690 | $ |
|
|||||||||||||||||||||||||||||||||||
| As of September 30, 2025 | As of December 31, 2024 | ||||||||||||||||||||||
|
2026 Notes
|
2028 Notes
|
2026 Notes
|
2028 Notes | ||||||||||||||||||||
| Principal | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Unamortized issuance costs |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net carrying amount | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Contractual interest expense | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Amortization of issuance costs |
|
|
|
|
|||||||||||||||||||
|
Total
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Cost of revenue | |||||||||||||||||||||||
|
Subscription and support
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Professional services
|
|
|
|
|
|||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
|
Research and development
|
|
|
|
|
|||||||||||||||||||
|
Sales and marketing
|
|
|
|
|
|||||||||||||||||||
|
General and administrative
|
|
|
|
|
|||||||||||||||||||
|
Total
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
|
Options
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contractual
Term (Years)
|
||||||||||||||||||||
| Outstanding at December 31, 2024 |
|
$ |
|
|
|||||||||||||||||||
| Exercised |
(
|
|
|||||||||||||||||||||
| Outstanding at September 30, 2025 |
|
$ |
|
|
|||||||||||||||||||
| Exercisable at September 30, 2025 |
|
$ |
|
|
|||||||||||||||||||
|
|
Number of Shares
|
Weighted-
Average
Grant Date Fair Value
|
|||||||||
| Unvested at December 31, 2024 |
|
$ |
|
||||||||
| Granted |
|
|
|||||||||
| Forfeited |
(
|
|
|||||||||
|
Vested
(1)
|
(
|
|
|||||||||
| Unvested at September 30, 2025 |
|
$ |
|
||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Subscription and support | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| XBRL professional services |
|
|
|
|
|||||||||||||||||||
| Other services |
|
|
|
|
|||||||||||||||||||
|
Total
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| As of September 30, 2025 | As of December 31, 2024 | ||||||||||||||||||||||||||||||||||||||||
| Weighted Average Useful Life (Years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||||||||||||||||||||||||||||||||
| Acquired technology |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||
| Acquired customer-related |
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Acquired trade names |
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Patents |
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Total |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||
| Remainder of 2025 | $ |
|
|||
| 2026 |
|
||||
| 2027 |
|
||||
| 2028 |
|
||||
| 2029 |
|
||||
| Thereafter |
|
||||
| Total expected amortization expense | $ |
|
|||
| Balance at December 31, 2024 | $ |
|
|||
| Foreign currency translation adjustments |
|
||||
| Balance at September 30, 2025 | $ |
|
|||
| Three months ended | |||||||||||||||||||||||
| September 30, 2025 | September 30, 2024 | ||||||||||||||||||||||
|
Class A
|
Class B
|
Class A
|
Class B
|
||||||||||||||||||||
|
Basic net income (loss) per share
|
|||||||||||||||||||||||
| Numerator | |||||||||||||||||||||||
|
Net income (loss), basic
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Denominator | |||||||||||||||||||||||
| Weighted-average shares outstanding, basic |
|
|
|
|
|||||||||||||||||||
|
Net income (loss) per share, basic
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
Diluted net income (loss) per share
|
|||||||||||||||||||||||
| Numerator | |||||||||||||||||||||||
|
Net income (loss), basic
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
Interest on convertible notes, net of tax
|
|
|
|
|
|||||||||||||||||||
|
Net income (loss), diluted
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Denominator | |||||||||||||||||||||||
| Weighted-average shares outstanding, basic |
|
|
|
|
|||||||||||||||||||
|
Weighted-average effect of dilutive securities:
|
|||||||||||||||||||||||
| Employee share-based awards |
|
|
|
|
|||||||||||||||||||
| Convertible senior notes |
|
|
|
|
|||||||||||||||||||
|
Number of shares used in diluted calculation
|
|
|
|
|
|||||||||||||||||||
|
Net income (loss) per share, diluted
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Nine months ended | |||||||||||||||||||||||
| September 30, 2025 | September 30, 2024 | ||||||||||||||||||||||
|
Class A
|
Class B
|
Class A
|
Class B
|
||||||||||||||||||||
|
Basic and diluted net loss per share
|
|||||||||||||||||||||||
| Numerator | |||||||||||||||||||||||
|
Net loss, basic and diluted
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Denominator | |||||||||||||||||||||||
|
Weighted-average shares outstanding, basic and diluted
|
|
|
|
|
|||||||||||||||||||
|
Net loss per share, basic and diluted
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Shares subject to outstanding common stock options |
|
|
|
|
|||||||||||||||||||
| Shares subject to unvested restricted stock units and performance restricted stock units |
|
|
|
|
|||||||||||||||||||
| Shares issuable pursuant to the ESPP |
|
|
|
|
|||||||||||||||||||
|
Shares underlying our convertible senior notes
|
|
|
|
|
|||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
|
Subscription and support revenue
|
|||||||||||||||||||||||
| Americas | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other |
|
|
|
|
|||||||||||||||||||
| Professional services revenue | |||||||||||||||||||||||
| Americas |
|
|
|
|
|||||||||||||||||||
| Other |
|
|
|
|
|||||||||||||||||||
|
Total
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| As of September 30, 2025 | As of December 31, 2024 | ||||||||||
| Americas | $ |
|
$ |
|
|||||||
| Other |
|
|
|||||||||
|
Total
|
$ |
|
$ |
|
|||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (dollars in thousands) | |||||||||||||||||||||||
| Financial metrics | |||||||||||||||||||||||
|
Total revenue
|
$ | 224,166 | $ | 185,621 | $ | 645,633 | $ | 538,791 | |||||||||||||||
| Percentage increase in total revenue | 20.8 | % | 17.4 | % | 19.8 | % | 16.3 | % | |||||||||||||||
| Subscription and support revenue | $ | 209,560 | $ | 171,035 | $ | 593,295 | $ | 486,749 | |||||||||||||||
| Percentage increase in subscription and support revenue | 22.5 | % | 19.3 | % | 21.9 | % | 18.8 | % | |||||||||||||||
| Subscription and support as a percent of total revenue | 93.5 | % | 92.1 | % | 91.9 | % | 90.3 | % | |||||||||||||||
| As of September 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Operating metrics | |||||||||||
| Number of customers | 6,541 | 6,237 | |||||||||
| Gross retention rate | 97.3% | 97.5% | |||||||||
| Net retention rate | 113.6% | 110.5% | |||||||||
| Number of customers with annual contract value $100k+ | 2,372 | 1,926 | |||||||||
| Number of customers with annual contract value $300k+ | 541 | 383 | |||||||||
| Number of customers with annual contract value $500k+ | 236 | 166 | |||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Subscription and support revenue from customers with annual contract value of $100k+ as a percent of total subscription and support revenue | 77.6% | 71.8% | 76.1% | 70.3% | |||||||||||||||||||
| Subscription and support revenue from customers with annual contract value of $300k+ as a percent of total subscription and support revenue | 42.1% | 36.0% | 40.3% | 35.1% | |||||||||||||||||||
| Subscription and support revenue from customers with annual contract value of $500k+ as a percent of total subscription and support revenue | 28.4% | 24.3% | 27.0% | 23.5% | |||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
|
(in thousands)
|
|||||||||||||||||||||||
| Revenue | |||||||||||||||||||||||
| Subscription and support | $ | 209,560 | $ | 171,035 | $ | 593,295 | $ | 486,749 | |||||||||||||||
| Professional services | 14,606 | 14,586 | 52,338 | 52,042 | |||||||||||||||||||
| Total revenue | 224,166 | 185,621 | 645,633 | 538,791 | |||||||||||||||||||
| Cost of revenue | |||||||||||||||||||||||
|
Subscription and support
(1)
|
33,824 | 30,621 | 103,163 | 86,493 | |||||||||||||||||||
|
Professional services
(1)
|
12,554 | 13,050 | 41,100 | 39,873 | |||||||||||||||||||
| Total cost of revenue | 46,378 | 43,671 | 144,263 | 126,366 | |||||||||||||||||||
| Gross profit | 177,788 | 141,950 | 501,370 | 412,425 | |||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
|
Research and development
(1)
|
51,403 | 48,425 | 160,026 | 142,328 | |||||||||||||||||||
|
Sales and marketing
(1)
|
101,127 | 89,756 | 306,823 | 257,086 | |||||||||||||||||||
|
General and administrative
(1)
|
28,663 | 25,551 | 84,822 | 76,225 | |||||||||||||||||||
| Total operating expenses | 181,193 | 163,732 | 551,671 | 475,639 | |||||||||||||||||||
| Loss from operations | (3,405) | (21,782) | (50,301) | (63,214) | |||||||||||||||||||
| Interest income | 8,442 | 9,298 | 25,533 | 30,089 | |||||||||||||||||||
| Interest expense | (3,195) | (3,199) | (9,584) | (9,668) | |||||||||||||||||||
| Other income (expense), net | 318 | (350) | (651) | (309) | |||||||||||||||||||
| Income (loss) before provision for income taxes | 2,160 | (16,033) | (35,003) | (43,102) | |||||||||||||||||||
| (Benefit) provision for income taxes | (626) | 959 | 2,982 | 3,125 | |||||||||||||||||||
| Net income (loss) | $ | 2,786 | $ | (16,992) | $ | (37,985) | $ | (46,227) | |||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
|
(in thousands)
|
|||||||||||||||||||||||
| Cost of revenue | |||||||||||||||||||||||
|
Subscription and support
|
$ | 2,635 | $ | 2,164 | $ | 7,579 | $ | 5,708 | |||||||||||||||
|
Professional services
|
1,102 | 858 | 3,204 | 2,348 | |||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
|
Research and development
|
6,592 | 5,681 | 19,198 | 15,474 | |||||||||||||||||||
|
Sales and marketing
|
9,855 | 9,942 | 29,496 | 26,470 | |||||||||||||||||||
|
General and administrative
|
10,062 | 8,825 | 27,124 | 25,879 | |||||||||||||||||||
|
Total stock-based compensation expense
|
$ | 30,246 | $ | 27,470 | $ | 86,601 | $ | 75,879 | |||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Revenue | |||||||||||||||||||||||
| Subscription and support | 93.5 | % | 92.1 | % | 91.9 | % | 90.3 | % | |||||||||||||||
| Professional services | 6.5 | 7.9 | 8.1 | 9.7 | |||||||||||||||||||
| Total revenue | 100.0 | 100.0 | 100.0 | 100.0 | |||||||||||||||||||
| Cost of revenue | |||||||||||||||||||||||
| Subscription and support | 15.1 | 16.5 | 16.0 | 16.1 | |||||||||||||||||||
| Professional services | 5.6 | 7.0 | 6.4 | 7.4 | |||||||||||||||||||
| Total cost of revenue | 20.7 | 23.5 | 22.4 | 23.5 | |||||||||||||||||||
| Gross profit | 79.3 | 76.5 | 77.6 | 76.5 | |||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
| Research and development | 22.9 | 26.1 | 24.8 | 26.4 | |||||||||||||||||||
| Sales and marketing | 45.1 | 48.4 | 47.5 | 47.7 | |||||||||||||||||||
| General and administrative | 12.8 | 13.8 | 13.1 | 14.1 | |||||||||||||||||||
| Total operating expenses | 80.8 | 88.3 | 85.4 | 88.2 | |||||||||||||||||||
| Loss from operations | (1.5) | (11.8) | (7.8) | (11.7) | |||||||||||||||||||
| Interest income | 3.8 | 5.0 | 4.0 | 5.6 | |||||||||||||||||||
| Interest expense | (1.4) | (1.7) | (1.5) | (1.8) | |||||||||||||||||||
| Other income (expense), net | 0.1 | (0.2) | (0.1) | (0.1) | |||||||||||||||||||
| Income (loss) before provision for income taxes | 1.0 | (8.7) | (5.4) | (8.0) | |||||||||||||||||||
| (Benefit) provision for income taxes | (0.3) | 0.5 | 0.5 | 0.6 | |||||||||||||||||||
| Net income (loss) | 1.3 | % | (9.2) | % | (5.9) | % | (8.6) | % | |||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2025 | 2024 |
% Change
|
2025 | 2024 |
% Change
|
|||||||||||||||||||||||||||||||||
|
(dollars in thousands)
|
||||||||||||||||||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||||||||||||||
|
Subscription and support
|
$ | 209,560 | $ | 171,035 | 22.5% | $ | 593,295 | $ | 486,749 | 21.9% | ||||||||||||||||||||||||||||
|
Professional services
|
14,606 | 14,586 | 0.1% | 52,338 | 52,042 | 0.6% | ||||||||||||||||||||||||||||||||
|
Total revenue
|
$ | 224,166 | $ | 185,621 | 20.8% | $ | 645,633 | $ | 538,791 | 19.8% | ||||||||||||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Cost of revenue | ||||||||||||||||||||||||||||||||||||||
|
Subscription and support
|
$ | 33,824 | $ | 30,621 | 10.5% | $ | 103,163 | $ | 86,493 | 19.3% | ||||||||||||||||||||||||||||
|
Professional services
|
12,554 | 13,050 | (3.8)% | 41,100 | 39,873 | 3.1% | ||||||||||||||||||||||||||||||||
|
Total cost of revenue
|
$ | 46,378 | $ | 43,671 | 6.2% | $ | 144,263 | $ | 126,366 | 14.2% | ||||||||||||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | ||||||||||||||||||||||||||||||||||||||
| Operating expenses | ||||||||||||||||||||||||||||||||||||||
|
Research and development
|
$ | 51,403 | $ | 48,425 | 6.1% | $ | 160,026 | $ | 142,328 | 12.4% | ||||||||||||||||||||||||||||
|
Sales and marketing
|
101,127 | 89,756 | 12.7% | 306,823 | 257,086 | 19.3% | ||||||||||||||||||||||||||||||||
|
General and administrative
|
28,663 | 25,551 | 12.2% | 84,822 | 76,225 | 11.3% | ||||||||||||||||||||||||||||||||
|
Total operating expenses
|
$ | 181,193 | $ | 163,732 | 10.7% | $ | 551,671 | $ | 475,639 | 16.0% | ||||||||||||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||||||||||||||||||||||||||||
|
(dollars in thousands)
|
||||||||||||||||||||||||||||||||||||||
| Interest income | $ | 8,442 | $ | 9,298 | (9.2)% | $ | 25,533 | $ | 30,089 | (15.1)% | ||||||||||||||||||||||||||||
|
Interest expense
|
(3,195) | (3,199) | (0.1)% | (9,584) | (9,668) | (0.9)% | ||||||||||||||||||||||||||||||||
| Other income (expense), net | 318 | (350) | * | (651) | (309) | * | ||||||||||||||||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
|
(in thousands)
|
|||||||||||||||||||||||
| Cash flow provided by operating activities | $ | 46,155 | $ | 18,906 | $ | 89,108 | $ | 43,736 | |||||||||||||||
| Cash flow used in investing activities | (10,107) | (49,629) | (23,523) | (58,496) | |||||||||||||||||||
| Cash flow (used in) provided by financing activities | (3,568) | 8,675 | (57,487) | 5,868 | |||||||||||||||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash, net of impact of exchange rates | $ | 31,661 | $ | (19,658) | $ | 14,276 | $ | (7,967) | |||||||||||||||
|
Total Number of
Shares Purchased
|
Average Price
Paid per Share
|
Total Number of
Shares
Purchased as Part of
Publicly Announced
Plans or Programs
|
Approximate Dollar Value that May Yet Be Purchased Under the Plans or Programs | ||||||||||||||||||||
| July 1, 2025 to July 31, 2025 | — | $ | — | — | $ | 49,892 | |||||||||||||||||
| August 1, 2025 to August 31, 2025 | — | $ | — | — | $ | 49,892 | |||||||||||||||||
|
September 1, 2025 to September 30, 2025
|
126,304 | $ | 79.17 | 126,304 | $ | 39,893 | |||||||||||||||||
| Total | 126,304 | 126,304 | |||||||||||||||||||||
|
Exhibit
Number
|
Description | |||||||
| 10.1 | ||||||||
| 10.2 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 32.2 | ||||||||
| 101 |
The following financial information from Workiva Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 formatted in Inline XBRL (Extensible Business Reporting Language) includes: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Income (Loss), (iv) the Consolidated Statements of Changes in Stockholders Deficit, (v) the Consolidated Statements of Cash Flows, and (vi) Notes to the Consolidated Financial Statements.
|
|||||||
| 104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
|
|||||||
|
WORKIVA INC.
|
|||||
|
By:
|
/s/ Julie Iskow | ||||
|
Name:
|
Julie Iskow | ||||
|
Title:
|
President and Chief Executive Officer | ||||
|
By:
|
/s/ Jill Klindt
|
||||
|
Name:
|
Jill Klindt
|
||||
|
Title:
|
Executive Vice President, Chief Financial Officer and Treasurer
|
||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|